Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Mirtazapine
Cat. No.:
OB0225LY-0177
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Mirtazapine is an antidepressant that works primarily by modulating neurotransmitters.
Synonym:
6-Azamianserin; Org3770; 85650-52-8; 2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine; Mirataz; Mirtazapin; Mirtazapine anhydrous; 2-Methyl-1,2,3,4,10,14b-hexahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepine
CAS No.:
85650-52-8
Compound CID:
4205
Formula:
C17H19N3
Formula Weight:
265.35
Specification
Relative Density:
1.22 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Mirtazapine can be used in antidepressant drug studies.
Library Information
Targets:
G protein-coupled receptors (GPCRs)
Receptors:
5-HT receptor; Adrenergic receptor; DA transporter; Dopamine receptor; Histamine receptor; Sert (Sodium-dependent); κ-Opioid receptor
Pathways:
Neuronal signaling; Endocrinology/Hormones; Immunology/Inflammation; GPCR/G protein
Plate Number:
AOCL-3
Plate Location:
b10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 207.27 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
53 mg/mL; 199.73 mM
